Beauty giants target ‘Ozempic face’ as boom in obesity drugs opens new market
BNN Bloomberg ·
Swiss skincare firm Galderma, Brazilian cosmetics group Natura and beauty giant L’Oreal are testing treatments for consumers worried about facial sagging and volume loss, looking to capitalize on a growing market tied to the boom in obesity drugs.
Publication and source information
- Platform
- NewsTiVi
- Source
- BNN Bloomberg
- Published
- 10/22/2026, 12:25:05 AM
- Country
- Canada
The headline and summary are supplied by the publisher. Read the full report on the source website.
Contact: info@newstivi.com